Laminin-111 protein therapy prevents muscle disease in the <i>mdx</i> mouse model for Duchenne muscular dystrophy

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a devastating neuromuscular disease caused by mutations in the gene encoding dystrophin. Loss of dystrophin results in reduced sarcolemmal integrity and increased susceptibility to muscle damage. The alpha(7)beta(1)-integrin is a laminin-binding protein up-regulated in the skeletal muscle of DMD patients and in the mdx mouse model. Transgenic overexpression of the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Exercise and Physiological Responses
• Share to Muscle Physiology and Disorders
• Share to Silk-based biomaterials and applications